Impact of insulin and glucocorticoid signalling on hepatic glucose homeostasis in the rat exposed to high-fructose diet and chronic stress

References

• Baena M, Sangüesa G, Dávalos A, Latasa MJ, Sala-Vila A, Sánchez RM, Roglans N, Laguna JC, Alegret M. 2016. Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues. Sci Rep. 6(1):1–15.
   PubMedGoogle Scholar
• Bojsen-Møller KN, Lundsgaard AM, Madsbad S, Kiens B, Holst JJ. 2018. Hepatic insulin clearance in regulation of systemic insulin concentrations—role of carbohydrate and energy availability. Diabetes. 67(11):2129–2136.
   PubMed Web of Science ®Google Scholar
• Bursać B, Djordjevic A, Veličković N, Milutinović DV, Petrović S, Teofilović A, Gligorovska L, Preitner F, Tappy L, Matić G. 2018. Involvement of glucocorticoid prereceptor metabolism and signaling in rat visceral adipose tissue lipid metabolism after chronic stress combined with high-fructose diet. Mol Cell Endocrinol. 476:110–118.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tripathy D. 2009. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 32(suppl_2):S157–S163.
   PubMedGoogle Scholar
• Douard V, Ferraris RP. 2013. The role of fructose transporters in diseases linked to excessive fructose intake. J Physiol. 591(2):401–414.
   PubMed Web of Science ®Google Scholar
• Erejuwa OO, Sulaiman SA, Wahab M. 2012. Fructose might contribute to the hypoglycemic effect of honey. Molecules. 17(2):1900–1915.
   PubMed Web of Science ®Google Scholar
• Gual P, Le Marchand-Brustel Y, Tanti JF. 2005. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie. 87(1):99–109.
   PubMed Web of Science ®Google Scholar
• Guiducci L, Iervasi G, Quinones-Galvan A. 2014. On the paradox insulin resistance/insulin hypersensitivity and obesity: two tales of the same history. Expert Rev Cardiovasc Ther. 12(6):637–642.
   PubMedGoogle Scholar
• Holvoet P. 2012. Stress in obesity and associated metabolic and cardiovascular disorders. Scientifica. 2012:205027.
   PubMedGoogle Scholar
• Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K. 2008. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11β-hydroxysteroid dehydrogenase type 1) gene. Mol Cell Endocrinol. 285(1–2):10–18.
   PubMed Web of Science ®Google Scholar
• Iynedjian PB, Jotterand D, Nouspikel T, Asfari M, Pilot PR. 1989. Transcriptional induction of glucokinase gene by insulin in cultured liver cells and its repression by the glucagon-cAMP system. J Biol Chem. 264 (36):21824–21829.
   PubMed Web of Science ®Google Scholar
• Joëls M, Karst H, Alfarez D, Heine VM, Qin Y, Riel E, van Verkuyl M, Lucassen PJ, Krugers HJ. 2004. Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress. 7(4):221–231.
   PubMed Web of Science ®Google Scholar
• Kovačević S, Nestorov J, Matić G, Elaković I. 2019. Chronic stress combined with a fructose diet reduces hypothalamic insulin signaling and antioxidative defense in female rats. Neuroendocrinology. 108(4):278–290.
   PubMed Web of Science ®Google Scholar
• Li Z, Frey JL, Wong GW, Faugere MC, Wolfgang MJ, Kim JK, Riddle RC, Clemens TL. 2016. Glucose transporter-4 facilitates insulin-stimulated glucose uptake in osteoblasts. Endocrinology. 157(11):4094–4103.
   PubMed Web of Science ®Google Scholar
• Li L, Li X, Zhou W, Messina JL. 2013. Acute psychological stress results in the rapid development of insulin resistance. J Endocrinol. 217(2):175–184.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2 − δδct method. Methods. 25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Massa ML, Gagliardino JJ, Francini F. 2011. Liver glucokinase: an overview on the regulatorymechanisms of its activity. IUBMB Life. 63(1):1–6.
   PubMed Web of Science ®Google Scholar
• Nasiri M, Nikolaou N, Parajes S, Krone NP, Valsamakis G, Mastorakos G, Hughes B, Taylor A, Bujalska IJ, Gathercole LL, Tomlinson JW. 2015. 5α-reductase type 2 regulates glucocorticoid action and metabolic phenotype in human hepatocytes. Endocrinology. 156(8):2863–2871.
   PubMed Web of Science ®Google Scholar
• Ono H, Shimano H, Katagiri H, Yahagi N, Sakoda H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Viana AYI, et al. 2003. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes. 52(12):2905–2913.
   PubMed Web of Science ®Google Scholar
• Owen C, Lees EK, Grant L, Zimmer DJ, Mody N, Bence KK, Delibegović M. 2013. Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice. Diabetologia. 56(10):2286–2296.
   PubMed Web of Science ®Google Scholar
• Pasieka A, Rafacho A. 2016. Impact of glucocorticoid excess on glucose tolerance: clinical and preclinical evidence. Metabolites. 6(3):24.
   Web of Science ®Google Scholar
• Pederson TM, Kramer DL, Rondinone CM. 2001. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes. 50(1):24–31.
   PubMed Web of Science ®Google Scholar
• Rui L. 2014. Energy metabolism in the liver. Compr Physiol. 4(1):177–197.
   PubMed Web of Science ®Google Scholar
• Spector T. 1978. Refinement of the coomassie blue method of protein quantitation: a simple and linear spectrophotometric assay for ≤0.5 to 50 μg of protein. Anal Biochem. 86(1):142–146.
   PubMed Web of Science ®Google Scholar
• Stewart MJ, Parikh S, Xiao G, Tonge PJ, Kisker C. 1999. Structural basis and mechanism of enoyl reductase inhibition by triclosan. J Mol Biol. 290(4):859–865.
   PubMed Web of Science ®Google Scholar
• Tang CY, Man XF, Guo Y, Tang HN, Tang J, Zhou CL, Tan SW, Wang M, Zhou HD. 2017. IRS-2 partially compensates for the insulin signal defects in irs-1−/− mice mediated by miR-33. Mol Cells. 40(2):123–132.
   PubMed Web of Science ®Google Scholar
• Tappy L, Lê KA. 2010. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 90(1):23–46.
   PubMed Web of Science ®Google Scholar
• Thorens B. 2015. GLUT2, glucose sensing and glucose homeostasis. Diabetologia. 58(2):221–232.
   PubMed Web of Science ®Google Scholar
• Titchenell PM, Quinn WJ, Lu M, Chu Q, Lu W, Li C, Chen H, Monks BR, Chen J, Rabinowitz JD, et al. 2016. Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production. Cell Metab. 23(6):1154–1166.
   PubMed Web of Science ®Google Scholar
• Tzivion G, Dobson M, Ramakrishnan G. 2011. FoxO transcription factors; regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta. 1813(11):1938–1945.
   PubMed Web of Science ®Google Scholar
• Vasiljević A, Bursać B, Djordjevic A, Milutinović DV, Nikolić M, Matić G, Veličković N. 2014. Hepatic inflammation induced by high-fructose diet is associated with altered 11βHSD1 expression in the liver of Wistar rats. Eur J Nutr. 53(6):1393–1402.
   PubMed Web of Science ®Google Scholar
• Vasiljević A, Veličković N, Bursać B, Djordjevic A, Milutinović DV, Nestorović N, Matić G. 2013. Enhanced prereceptor glucocorticoid metabolism and lipogenesis impair insulin signaling in the liver of fructose-fed rats. J Nutr Biochem. 24(11):1790–1797.
   PubMed Web of Science ®Google Scholar
• Veličković N, Djordjevic A, Vasiljević A, Bursać B, Milutinović DV, Matić G. 2013. Tissue-specific regulation of inflammation by macrophage migration inhibitory factor and glucocorticoids in fructose-fed Wistar rats. Br J Nutr. 110(3):456–465.
   PubMed Web of Science ®Google Scholar
• Veličković N, Teofilović A, Ilić D, Djordjevic A, Vojnović MD, Petrović S, Preitner F, Tappy L, Matić G. 2019. Modulation of hepatic inflammation and energy-sensing pathways in the rat liver by high-fructose diet and chronic stress. Eur J Nutr. 58(5):1829–1845.
   PubMed Web of Science ®Google Scholar
• Wang M. 2005. The role of glucocorticoid action in the pathophysiology of the metabolic syndrome. Nutr Metab. 2 (1):3.
   Google Scholar
• Watford M. 2002. Small amounts of dietary fructose dramatically increase hepatic glucose uptake through a novel mechanism of glucokinase activation. Nutr Rev. 60(8):253–257.
   PubMed Web of Science ®Google Scholar
• White PC, Rogoff D, McMillan DR, Lavery GG. 2007. Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism. Mol Cell Endocrinol. 265–266:89–92.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhao CX, Wang L, Tu L, Fang X, Zheng C, Edin ML, Zeldin DC, Wang DW. 2010. Increased CYP2J3 expression reduces insulin resistance in fructose-treated rats and db/db mice. Diabetes. 59(4):997–1005.
   PubMed Web of Science ®Google Scholar
• Zhang DM, Jiao RQ, Kong LD. 2017. High dietary fructose: direct or indirect dangerous factors disturbing tissue and organ functions. Nutrients. 9(4):335.
   PubMed Web of Science ®Google Scholar